Fundamentos neurobiológicos del abordaje psicofarmacológico del trastorno por déficit atencional con/sin hiperquinesia. Riesgo evolutivo y responsabilidad profesional / Neurological basis of the attention deficit disorder with hyperkinesia psychopharmacological treatment-evolution risk and professional liability
Psicofarmacologia (B. Aires)
; 12(77): 19-29, nov. 2012. tab
Article
in Es
| LILACS
| ID: lil-674952
Responsible library:
AR392.1
RESUMEN
El objetivo del presente trabajo es evaluar los riesgos resultantes de no realizar el abordaje psicofarmacológico adecuado al trastorno de déficit atencional con hiperquinesia en niños. Se analiza el riesgo evolutivo y en especial, las comorbilidades que presumiblemente podrían haberse neutralizado de haberse operado un tratamiento médico precoz. El estudio de las disfunciones neurobiológicas, en especial los aspectos derivados de las neuroimágenes y de la afectación de la neurotransmisión dan un soporte neurocientífico a la necesidad de un correcto abordaje médico del trastorno. Se apela finalmente a la responsabilidad profesional para no defeccionar de actuar y no caer en la negligente inacción terapéutica.
ABSTRACT
The aim of this study is to evaluate the risks resulting from not using the appropriate psychotropic approach to Attention Deficit Disorder with hyperkinesia in children. It analyzes the evolutionary risks, especially comorbidity, which presumably could neutralize itself should it be subjetct to early medical treatment. The study of neurobiological dysfunctions, especially those aspects derived from neuroimaging and neurotransmission involvement, provide neuroscientific support to the need for a correct medical approach to this disorder. Finally, this study stresses the respnsibility of all professionals in not failing to act, and not falling to the negligence of therapeutic inaction.
Key words
Search on Google
Index:
LILACS
Main subject:
Anxiety Disorders
/
Attention Deficit Disorder with Hyperactivity
/
Bipolar Disorder
/
Drug Administration Schedule
/
Comorbidity
/
Early Diagnosis
/
Depression
Type of study:
Diagnostic_studies
/
Etiology_studies
/
Evaluation_studies
/
Risk_factors_studies
/
Screening_studies
Limits:
Humans
Language:
Es
Journal:
Psicofarmacologia (B. Aires)
Journal subject:
FARMACOLOGIA
/
PSICOLOGIA
/
PSIQUIATRIA
Year:
2012
Type:
Article